Allow me to reintroduce myself — gMed completes rebrand: 4 insights

gMed, a Modernizing Medicine Co., completed its rebrand to become Modernizing Medicine Gastroenterology.

Advertisement

Here’s what you should know:

1. Modernizing Medicine will unveil the new brand at the American College of Gastroenterology 2018 annual meeting, Oct. 5-10 in Philadelphia.

2. Modernizing Medicine will also showcase gGastro mobile at the meeting. Physicians can view their schedule, search their EHR and view patient information with gGastro Mobile. gGastro Mobile works with the gGastro EHR solution and is available for both Apple and Android phones.

3. Modernizing Medicine acquired gMed in September 2015.

4. Modernizing Medicine Gastroenterology advisor Arnold Levy, MD, said, “This is an exciting chapter for the organization and we look forward to what’s ahead as Modernizing Medicine Gastroenterology embraces its new identity.”

More articles on gastroenterology:
Envision (AmSurg) launches campaign blaming surprise medical bills on insurance regulations — 6 insights
ASC supply chain tip of the day: Take advantage of GPO partnerships
Capitol Street Surgery Center, Surgicare Cross Pointe seek investors: 3 insights

At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.

Register to Attend Webinar

Unlocking Structural Heart Capacity: How Leading Programs Use EMR and Data to Improve Patient Flow and Throughput

Wednesday, August 19
11:00 AM - 12:00 PM CDT

Presenters: Katie Kennedy, MSN, APRN, NP-C, Community Heart and VascularMisty Theriot, BSN, RN, CPHQ, FACC, Lake Charles Memorial Health SystemKatie Worthington, DNP, RN, Atlantic Health SystemTaryn Shipley, MBA, CSSBB, Lean HealthTech

Advertisement

Next Up in GI & Endoscopy

Advertisement

Comments are closed.